From: Emergence of T cell immunosenescence in diabetic chronic kidney disease
 | Model 1 Adjusted for Age, Sex | Model 2 Adjusted for Age, Sex, CKD status | ||
---|---|---|---|---|
 | ß | p value | ß | p value |
CD4+ TNAIVE (%) | −0.13 | 0.36 | −0.19 | 0.20 |
CD4+ TEFF (%) | 0.0062 | 0.82 | 0.0081 | 0.77 |
CD4+ CD127+ (%) | −0.056 | 0.26 | −0.038 | 0.44 |
CD4+ CD28- (%) | 0.082 | 0.19 | 0.073 | 0.25 |
CD4+ CD57+ (%) | 0.027 | 0.48 | 0.023 | 0.56 |
CD8+ TNAIVE (%) | −0.20 | 0.083 | −0.17 | 0.15 |
CD8+ TEFF (%) | 0.25 | 0.17 | 0.20 | 0.28 |
CD8+ CD127+ (%) | −0.25 | 0.12 | −0.19 | 0.23 |
CD8+ CD28- (%) | 0.37 | 0.033* | 0.30 | 0.087 |
CD8+ CD57+ (%) | 0.42 | 0.0049* | 0.37 | 0.017* |